| Dr Michael Perez Mendez, MD | |
|
7008 Indiana Ave, Ste. A, Lubbock, TX 79413-6114 | |
| (806) 698-8088 | |
| (806) 698-8588 |
| Full Name | Dr Michael Perez Mendez |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 7008 Indiana Ave, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649433863 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | BP10032240 (Texas) | Secondary |
| 207Q00000X | Family Medicine | N5863 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Interim Healthcare Of West Texas Llc | Lubbock, TX | Home health agency |
| Calvert Home Health Care Ltd | Lubbock, TX | Home health agency |
| Encompass Home Health Of Lubbock | Lubbock, TX | Home health agency |
| Interim Hospice Of West Texas | Lubbock, TX | Hospice |
| Hospice Of Lubbock Inc | Lubbock, TX | Hospice |
| Area Community Hospice Inc | Plainview, TX | Hospice |
| Covenant Medical Center | Lubbock, TX | Hospital |
| Covenant Childrens Hospital | Lubbock, TX | Hospital |
| University Medical Center | Lubbock, TX | Hospital |
| Lubbock Health Care Center | Lubbock, TX | Nursing home |
| Heritage Oaks Nursing And Rehabilitation Center | Lubbock, TX | Nursing home |
| Bender Terrace Of Lubbock | Lubbock, TX | Nursing home |
| Lubbock Hospitality Nursing And Rehabilitation Cen | Lubbock, TX | Nursing home |
| Slaton Care Center | Slaton, TX | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lfm Associates | 4082020086 | 10 |
News Archive
Fibromyalgia affects as many as one in 50 Americans, 90 percent of whom are women. Yet, despite its nearly epidemic status, patients still often rely on pharmaceutical options solely for treatment. That's why Bioenergy Life Science, Inc. has introduced Corvalen M, a natural treatment option for fibromyalgia symptoms.
States across the country are making significant changes to their newborn screening programs after a Milwaukee Journal Sentinel investigation found that thousands of hospitals were sending babies' blood samples late to state labs that test for rare yet deadly genetic disorders. From keeping labs open on weekends to identifying problem hospitals and providing them with regular performance reports, dozens of health officials are reviewing and retooling their state-run programs (Gabler, 12/11).
Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington's disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.
Researchers at the University of Leeds have devised a more accurate method of dating ancient human migration - even when no corroborating archaeological evidence exists.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
› Verified 9 days ago
| Entity Name | Rodney T Franklin Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346373289 PECOS PAC ID: 1658262191 Enrollment ID: O20040323001330 |
News Archive
Fibromyalgia affects as many as one in 50 Americans, 90 percent of whom are women. Yet, despite its nearly epidemic status, patients still often rely on pharmaceutical options solely for treatment. That's why Bioenergy Life Science, Inc. has introduced Corvalen M, a natural treatment option for fibromyalgia symptoms.
States across the country are making significant changes to their newborn screening programs after a Milwaukee Journal Sentinel investigation found that thousands of hospitals were sending babies' blood samples late to state labs that test for rare yet deadly genetic disorders. From keeping labs open on weekends to identifying problem hospitals and providing them with regular performance reports, dozens of health officials are reviewing and retooling their state-run programs (Gabler, 12/11).
Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington's disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.
Researchers at the University of Leeds have devised a more accurate method of dating ancient human migration - even when no corroborating archaeological evidence exists.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
› Verified 9 days ago
| Entity Name | Lfm Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255925756 PECOS PAC ID: 4082020086 Enrollment ID: O20210316001849 |
News Archive
Fibromyalgia affects as many as one in 50 Americans, 90 percent of whom are women. Yet, despite its nearly epidemic status, patients still often rely on pharmaceutical options solely for treatment. That's why Bioenergy Life Science, Inc. has introduced Corvalen M, a natural treatment option for fibromyalgia symptoms.
States across the country are making significant changes to their newborn screening programs after a Milwaukee Journal Sentinel investigation found that thousands of hospitals were sending babies' blood samples late to state labs that test for rare yet deadly genetic disorders. From keeping labs open on weekends to identifying problem hospitals and providing them with regular performance reports, dozens of health officials are reviewing and retooling their state-run programs (Gabler, 12/11).
Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington's disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.
Researchers at the University of Leeds have devised a more accurate method of dating ancient human migration - even when no corroborating archaeological evidence exists.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Perez Mendez, MD 7008 Indiana Ave, Ste. A, Lubbock, TX 79413-6114 Ph: (806) 698-8088 | Dr Michael Perez Mendez, MD 7008 Indiana Ave, Ste. A, Lubbock, TX 79413-6114 Ph: (806) 698-8088 |
News Archive
Fibromyalgia affects as many as one in 50 Americans, 90 percent of whom are women. Yet, despite its nearly epidemic status, patients still often rely on pharmaceutical options solely for treatment. That's why Bioenergy Life Science, Inc. has introduced Corvalen M, a natural treatment option for fibromyalgia symptoms.
States across the country are making significant changes to their newborn screening programs after a Milwaukee Journal Sentinel investigation found that thousands of hospitals were sending babies' blood samples late to state labs that test for rare yet deadly genetic disorders. From keeping labs open on weekends to identifying problem hospitals and providing them with regular performance reports, dozens of health officials are reviewing and retooling their state-run programs (Gabler, 12/11).
Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington's disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.
Researchers at the University of Leeds have devised a more accurate method of dating ancient human migration - even when no corroborating archaeological evidence exists.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
› Verified 9 days ago
Charles Hudson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Concord Medical Group, 1602 Avenue Q, Lubbock, TX 79401 Phone: 972-829-6613 Fax: 800-611-5029 | |
Dr. Ronald L. Cook, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St, Suite 1c143, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-2563 | |
Dr. Scott W. Dahlbeck, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 602 Indiana Ave, Lubbock, TX 79415 Phone: 806-775-8600 Fax: 806-775-8608 | |
Naticia Mortensen, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5915 82nd St, Lubbock, TX 79424 Phone: 806-794-3000 Fax: 806-698-0847 | |
Ryan Daniel Lurtsema, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3601 4th Street Mail Stop 9901, Lubbock, TX 79430 Phone: 806-743-2757 Fax: 806-743-1180 | |
Dr. Cherrylene A Lindgren, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4105 I-27, Lubbock, TX 79404 Phone: 806-762-2633 Fax: 806-761-0431 | |
Jared Zachary Brinker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 |